Thalidomide ameliorates rosacea-like skin inflammation and suppresses NF-κB activation in keratinocytes

ConclusionsOur findings suggest thalidomide attenuates the inflammation and represses NF-κB activation in skin, which leads to assumptions that thalidomide may be a new therapeutic agent for rosacea.Graphical abstract
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research